S&P 500   3,087.01 (-0.20%)
DOW   27,691.49 (+0.04%)
QQQ   200.96 (-0.13%)
CGC   20.30 (-5.41%)
BABA   186.71 (-0.24%)
GE   11.35 (-1.48%)
T   39.37 (-0.03%)
ACB   3.62 (-4.99%)
BAC   33.18 (-0.24%)
DIS   136.74 (-0.88%)
S&P 500   3,087.01 (-0.20%)
DOW   27,691.49 (+0.04%)
QQQ   200.96 (-0.13%)
CGC   20.30 (-5.41%)
BABA   186.71 (-0.24%)
GE   11.35 (-1.48%)
T   39.37 (-0.03%)
ACB   3.62 (-4.99%)
BAC   33.18 (-0.24%)
DIS   136.74 (-0.88%)
Log in

Hospira Stock Price, Forecast & Analysis (NYSE:HSP)

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Hospira, Inc provides injectable pharmaceutical drugs and infusion technologies and it develops, manufactures, distributes and markets biosimilars. The Company's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. The Company conducts operations across the world and is managed in three segments: the Americas, which include the United States, Canada, and Latin America; Europe, Middle East, and Africa (EMEA), and the Asia Pacific, which includes Asia, Japan, Australia and New Zealand. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryPharmaceuticals
SectorN/A
CUSIP44106010
Phone+1-847-9376472

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive HSP News and Ratings via Email

Sign-up to receive the latest news and ratings for HSP and its competitors with MarketBeat's FREE daily newsletter.


Hospira (NYSE:HSP) Frequently Asked Questions

What is Hospira's stock symbol?

Hospira trades on the New York Stock Exchange (NYSE) under the ticker symbol "HSP."

How were Hospira's earnings last quarter?

Hospira, Inc. (NYSE:HSP) released its quarterly earnings results on Wednesday, July, 29th. The healthcare company reported $0.85 earnings per share for the quarter, beating analysts' consensus estimates of $0.78 by $0.07. The healthcare company earned $1.20 billion during the quarter, compared to the consensus estimate of $1.18 billion. The firm's quarterly revenue was up 4.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.72 earnings per share. View Hospira's Earnings History.

Has Hospira been receiving favorable news coverage?

News coverage about HSP stock has been trending very negative recently, according to InfoTrie Sentiment. The research group ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Hospira earned a coverage optimism score of -3.2 on InfoTrie's scale. They also gave news coverage about the healthcare company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for Hospira.

Who are some of Hospira's key competitors?

What other stocks do shareholders of Hospira own?

How do I buy shares of Hospira?

Shares of HSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Hospira's official website?

The official website for Hospira is http://www.hospira.com/.

How can I contact Hospira?

Hospira's mailing address is 275 N Field Dr, LAKE FOREST, IL 60045-2579, United States. The healthcare company can be reached via phone at +1-847-9376472.


MarketBeat Community Rating for Hospira (NYSE HSP)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  154 (Vote Outperform)
Underperform Votes:  254 (Vote Underperform)
Total Votes:  408
MarketBeat's community ratings are surveys of what our community members think about Hospira and other stocks. Vote "Outperform" if you believe HSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/11/2019 by MarketBeat.com Staff

Featured Article: What is Cost of Debt?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel